Pharma Mar, S.A.

Overview

PharmaMar is a biopharmaceutical company based in Spain, specializing in the discovery and development of innovative marine-derived drugs to treat cancer. The company focuses heavily on oncology and has several products and candidates in various stages of development.

Therapeutic areas

API / Drug Master Files

Pharma Mar, S.A. holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LURBINECTEDINActive2019-10-25
• TRABECTEDINActive2008-06-23

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Pharma Mar, S.A. in our records. PharmaTek screens the full directory against live FDA enforcement data.